Amyloid plaques and amyloid-beta oligomers: an ongoing debate.
Lesné
Sylvain
S
Department of Neurology, University of Minnesota, Minneapolis, Minnesota 55455, USA lesne002@tc.umn.edu.
Kotilinek
Linda
L
D000367:Age Factors; D000544:Alzheimer Disease / Q000150:complications / Q000378:metabolism*; D016229:Amyloid beta-Peptides / Q000276:immunology / Q000378:metabolism*; D000818:Animals; D000906:Antibodies / Q000627:therapeutic use; D003072:Cognition Disorders / Q000209:etiology / Q000628:therapy; D004195:Disease Models, Animal; D018450:Disease Progression; D017774:Long-Term Potentiation / Q000187:drug effects; D051379:Mice; D058225:Plaque, Amyloid / Q000378:metabolism*
D016229:Amyloid beta-Peptides; D000906:Antibodies